March 24, 2009 - INFINITT North America announced today it will launch the INFINITT Cardiology PACS, a complete image management solution for the cardiology enterprise that provides image management software and image acquisition, storage, display and Web distribution devices.

March 23, 2009 – CardiacAssist Inc. yesterday introduced a longer cannula set to cardiologists and cardiac surgeons to be used with its TandemHeart cardiac-assist device, the TandemHeart Transseptal Cannula Set—Enhanced Flow 72” (THTC-EF 72).

March 24, 2009 - Frost & Sullivan has awarded GE Healthcare with the 2009 Growth Strategy Leadership of the Year Award in Medical Imaging.

The award is based upon Frost & Sullivan’s recent analysis of the medical imaging market segment, which recognizes the growth path that GE embarked upon following its acquisition of Dynamic Imaging (DI) in October 2007.

March 24, 2009 - Efficacy and safety study results for Corthera's investigational drug relaxin for the treatment of acute heart failure (AHF) will be presented Sunday, March 29, during the American College of Cardiology's (ACC) 58th Annual Scientific Session in Orlando, FL.

March 24, 2009 - Frost & Sullivan has awarded Philips Healthcare with the 2009 North American Frost & Sullivan Product Innovation of the Year Award for its Brilliance iCT 256 slice and iCT SP 128 slice computed tomography (CT) systems.

March 24, 2009 - The Society of Chest Pain Centers’ new Acute Heart Failure Center Accreditation program is aimed at helping healthcare facilities improve patient outcomes and reduce costs through the use of process improvement methods to optimize best practices.


With the uncertain economic environment, many organizations are challenged by having to align shrinking budgets with their training and development needs. While professional development remains an essential part of organizational health, it can be costly, too.

March 23, 2009 – The FDA has cleared the Nellcor OxiMax N-600x pulse oximeter with OxiMax SPD alert for adults, which enables the pulse oximeter to detect and alert clinicians of oxygen desaturation patterns, allowing them to make timely and more informed decisions about patient care.

March 23, 2009 - Pathway Medical Technologies Inc. today said the FDA granted the company 510(k) clearance to market the Jetstream G2 specifically for use in breaking apart and removing thrombus (or blood clots) from the upper and lower extremity peripheral arteries.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now